Harvard Statistician Sherri Rose Receives NIH Director’s New Innovator Award

Harvard Medical School associate professor Sherri Rose has been recognized by the National Institutes of Health (NIH) with its prestigious Director’s New Innovator Award. An associate professor of health care policy (biostatistics, Rose was recognized for work developing generalizability methods for health outcomes.

“I continually point to this program as an example of the creative and revolutionary research NIH supports,” said NIH Director Francis S. Collins in a press release announcing the 2017 winners. “The quality of the investigators and the impact their research has on the biomedical field is extraordinary.”

Sherri Rose

Rose’s work is centered on developing and integrating innovative statistical approaches to advance human health. Her methodological research focuses on nonparametric machine learning for causal inference and prediction. Specifically within health policy, she focuses on risk adjustment, comparative effectiveness research, and health program impact evaluation. In addition to teaching and conducting research, Rose co-leads the Health Policy Data Science Lab, where she directs projects in computational health economics and health outcomes research.

Established in 2007, the NIH Director’s New Innovator Award is part of the “High-Risk, High-Reward Research” program, which was created to accelerate the pace of biomedical discoveries by supporting exceptionally creative scientists with highly innovative research. It seeks to identify scientists with high-impact ideas that may be risky or at a stage too early to fare well in the traditional peer-review process and encourages creative, outside-the-box thinkers to pursue exciting and innovative ideas in any area of biomedical research relevant to NIH’s mission.